I have two questions.
Q1: How long will Glenmark have patent protection and/or marketing exclusivity for Ryaltris?
Q2: What are the margins for Ryaltris are likely to be? Since Ryaltris is a novel drug combination so presumably the gross/operating margin for this product is likely to be significantly higher than generic formulations, right?
| Subscribe To Our Free Newsletter |
